The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction.

[1]  A. Lampen,et al.  Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes. , 2015, Toxicology.

[2]  William J. Allen,et al.  DOCK 6: Impact of new features and current docking performance , 2015, J. Comput. Chem..

[3]  U. Apte,et al.  Global gene expression changes in liver following hepatocyte nuclear factor 4 alpha deletion in adult mice , 2015, Genomics data.

[4]  Allan N. Williams,et al.  Biomonitoring for perfluorochemicals in a Minnesota community with known drinking water contamination. , 2014, Journal of environmental health.

[5]  Mitchell R. McGill,et al.  Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. , 2014, Toxicology and applied pharmacology.

[6]  Yonglong Lu,et al.  Associations between serum concentrations of perfluoroalkyl acids and serum lipid levels in a Chinese population. , 2014, Ecotoxicology and environmental safety.

[7]  H. Adami,et al.  A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans , 2014, Critical reviews in toxicology.

[8]  Han Bai,et al.  Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions. , 2014, Human pathology.

[9]  A. Shankar,et al.  The association between PFOA, PFOS and serum lipid levels in adolescents. , 2014, Chemosphere.

[10]  J. Corton,et al.  Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study , 2014, Critical reviews in toxicology.

[11]  Maura O'Neil,et al.  Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine‐induced hepatocellular carcinoma in rodents , 2013, Hepatology.

[12]  A. Kiss,et al.  Distinct Claudin Expression Profiles of Hepatocellular Carcinoma and Metastatic Colorectal and Pancreatic Carcinomas , 2013, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  A. Yu,et al.  Claudins and the modulation of tight junction permeability. , 2013, Physiological reviews.

[14]  S. Kliewer,et al.  Nuclear Receptors HNF4α and LRH-1 Cooperate in Regulating Cyp7a1 in Vivo* , 2012, The Journal of Biological Chemistry.

[15]  A. Lampen,et al.  Perfluorooctanoic acid affects the activity of the hepatocyte nuclear factor 4 alpha (HNF4α). , 2012, Toxicology letters.

[16]  J. Klaunig,et al.  Mode of Action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and Human Relevance. , 2012, Reproductive toxicology.

[17]  C. Lau.  Perfluoroalkyl acids: recent research highlights. , 2012, Reproductive toxicology.

[18]  B. Staels,et al.  Roles of PPARs in NAFLD: potential therapeutic targets. , 2012, Biochimica et biophysica acta.

[19]  J. Domingo,et al.  Health risks of dietary exposure to perfluorinated compounds. , 2012, Environment international.

[20]  G. Olsen,et al.  Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. , 2012, Toxicology.

[21]  C. Elcombe,et al.  Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR. , 2012, Toxicology.

[22]  T. Hielscher,et al.  Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis , 2012, Journal of cellular and molecular medicine.

[23]  F. Gonzalez,et al.  Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4α in Adult Mice* , 2012, The Journal of Biological Chemistry.

[24]  G. Konopka,et al.  HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells , 2011, Journal of Cell Science.

[25]  A. DeCaprio,et al.  Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project , 2011, Drug and chemical toxicology.

[26]  Mark J. Strynar,et al.  Polyfluorinated compounds: past, present, and future. , 2011, Environmental science & technology.

[27]  T. Okumura.  Role of lipid droplet proteins in liver steatosis , 2011, Journal of Physiology and Biochemistry.

[28]  Y. Barak,et al.  Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  F. Sladek,et al.  HNF4α--role in drug metabolism and potential drug target? , 2010, Current opinion in pharmacology.

[30]  J. Depierre,et al.  Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice. , 2010, International immunopharmacology.

[31]  Kun Wu,et al.  Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. , 2010, Cancer research.

[32]  J. Corton,et al.  Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects , 2010, PPAR research.

[33]  C. Martinez-Jimenez,et al.  Hepatocyte Nuclear Factor 4 (cid:1) Coordinates a Transcription Factor Network Regulating Hepatic Fatty Acid Metabolism (cid:1) , 2010 .

[34]  Fatihah Suja,et al.  Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper. , 2009, Water science and technology : a journal of the International Association on Water Pollution Research.

[35]  Ian T Cousins,et al.  Tracking the pathways of human exposure to perfluorocarboxylates. , 2009, Environmental science & technology.

[36]  J. Depierre,et al.  The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha). , 2009, Toxicology.

[37]  Eugene Bolotin,et al.  Identification of an Endogenous Ligand Bound to a Native Orphan Nuclear Receptor , 2009, PloS one.

[38]  C. Lau,et al.  Perfluorooctane sulfonate-induced changes in fetal rat liver gene expression. , 2008, Toxicology.

[39]  J Christopher Corton,et al.  Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  L. Beretta,et al.  Translational control plays a prominent role in the hepatocytic differentiation of HepaRG liver progenitor cells , 2008, Genome Biology.

[41]  N. Mitro,et al.  The pharmacological exploitation of cholesterol 7alpha-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol. , 2007, Pharmacology & therapeutics.

[42]  J. Gustafsson,et al.  Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis , 2007, Proceedings of the National Academy of Sciences.

[43]  C. Lau,et al.  Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  John W. Froehlich,et al.  Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.

[45]  R. Ahima,et al.  Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide. , 2007, Gastroenterology.

[46]  L. Shaw,et al.  Community Exposure to Perfluorooctanoate: Relationships Between Serum Concentrations and Exposure Sources , 2006, Journal of occupational and environmental medicine.

[47]  C. Lau,et al.  Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[48]  B. Schreiber,et al.  PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes , 2005 .

[49]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[50]  C. Lau,et al.  The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.

[51]  S. Shoelson,et al.  Structural Basis for HNF-4α Activation by Ligand and Coactivator Binding* , 2004, Journal of Biological Chemistry.

[52]  D. Ovchinnikov,et al.  Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors , 2004, Hepatology.

[53]  K. Okita,et al.  Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. , 2004, Biochemical and biophysical research communications.

[54]  Roger G Perkins,et al.  The Toxicology of Perfluorooctanoate , 2004, Critical reviews in toxicology.

[55]  M. Reitman,et al.  Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass* , 2003, Journal of Biological Chemistry.

[56]  M. Stanton,et al.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[57]  J. Adamson,et al.  Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis , 2003, Nature Genetics.

[58]  S. Duncan,et al.  HNF4: A central regulator of hepatocyte differentiation and function , 2003, Hepatology.

[59]  Yoichi Kawashima,et al.  Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. , 2003, The Journal of toxicological sciences.

[60]  James E Klaunig,et al.  The Human Relevance of Information on Carcinogenic Modes of Action: Overview , 2003, Critical reviews in toxicology.

[61]  David Y. Lai,et al.  PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance , 2003 .

[62]  Timothy M Willson,et al.  Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. , 2002, Structure.

[63]  Roland L. Dunbrack.  Rotamer libraries in the 21st century. , 2002, Current opinion in structural biology.

[64]  Celeste Eng,et al.  Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. , 2002, The Journal of clinical investigation.

[65]  S. Young,et al.  Human CYP7A1 deficiency: progress and enigmas. , 2002, The Journal of clinical investigation.

[66]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[67]  Naohiro Terada,et al.  Hepatic maturation in differentiating embryonic stem cells in vitro , 2001, FEBS letters.

[68]  K. Fujimoto,et al.  Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[69]  J. Gleason,et al.  Associations of perfluorinated chemical serum concentrations and biomarkers of liver function and uric acid in the US population (NHANES), 2007-2010. , 2015, Environmental research.

[70]  Udayan Apte,et al.  Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer. , 2015, Gene expression.

[71]  P. Ganey,et al.  Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[72]  U. Apte,et al.  Hepatocyte-specific deletion of hepatocyte nuclear factor-4α in adult mice results in increased hepatocyte proliferation. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[73]  Paul D. Jones,et al.  Aquatic toxicology of perfluorinated chemicals. , 2010, Reviews of environmental contamination and toxicology.

[74]  Pim de Voogt,et al.  Perfluorinated substances in human food and other sources of human exposure. , 2010, Reviews of environmental contamination and toxicology.

[75]  R. Luebke,et al.  Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. , 2009, Critical reviews in toxicology.

[76]  B. Schreiber,et al.  PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. , 2005, American journal of physiology. Endocrinology and metabolism.

[77]  James E Klaunig,et al.  PPARalpha agonist-induced rodent tumors: modes of action and human relevance. , 2003, Critical reviews in toxicology.